In eWAT, the mRNA expression of glycerophospholipid metabolism signaling pathway genes (LCAT, DGK, PLD1, PLD2) were up-regulated and EPT1 and LPCAT2 were down-regulated in the BC group compared to the HFD group. The gene discussed is PLD2; the disease is breast cancer.